Últimas noticias sobre Procter & Gamble (NYSE:PG) Bolsa

Procter & Gamble

Since its founding in 1837, Procter & Gamble has become one of the world's largest consumer product manufacturers, generating more than $80 billion in annual sales. It operates with a lineup of leading brands, including more than 20 that generate north of $1 billion each in annual global sales, such as Tide laundry detergent, Charmin toilet paper, Pantene shampoo, and Pampers diapers. Sales outside its home turf represent more than half of the firm's consolidated total.

Procter & Gamble Company (The) Common Stock

Procter & Gamble Co

PGI Inc

Global X Funds Global X MSCI Portugal ETF

Petrogress Inc

PPB Group Bhd

Peapack-Gladstone Financial Corporation - Common Stock

Peapack Gladstone Financial Corp

PUREGOLD PRICE CLUB INC by Puregold Price Club Inc.

Puregold Price Club Inc

PTT Global Chemical PCL

PROSEGUR CIA DE SECURIDAD by Prosegur Cia De Securidad SA

Prosegur Compania De Seguridad SA

PGD ECO SOLUTIONS INC by PGD ECO SOLUTIONS INC.

PGD Eco Solutions Inc

PGS ASA

PGS ORD

Precigen Inc

Pigeon Corp

STILLWATER CRITICAL MNRLS by STILLWATER CRITICAL MINERALS CORP.

Stillwater Critical Minerals Corp

Invesco Financial Preferred ETF

PIONEER GREEN FARMS INC by PIONEER GREEN FARMS INC.

Pioneer Green Farms Inc

PINGIFY INTERNATIONAL INC by Pingify International Inc.

Pingify International Inc

INVSC FINANCIAL PREFERRED ETF

PIAGGIO & C SPA UNSP/ADR by Piaggio & C Spa Pontedera

Piaggio & C. SpA

PEGASUS GAMING CORP by Pegasus Gaming Corp.

Primega Group Holdings Limited - Ordinary Shares

Primega Group Holdings Ltd

Invesco Global ex-US High Yield Corporate Bond ETF

PEREGRINE INDUS INC by Peregrine Industries, Inc.

Peregrine Industries Inc

PGI Energy Inc

PRESTIGE INTL INC (JAPAN) by Prestige International Inc.

Prestige International Inc

Invesco Golden Dragon China ETF

INVSC GOLDEN DRAGON ETF

P2 Gold Inc

PRIMEGEN ENERGY CORP by Primegen Energy Corp.

Primegen Energy Corp

PARAGON FINCL SLTNS INC by Paragon Financial Solutions, Inc. (TN)

Paragon Financial Solutions Inc

Pan Global Resources Inc

PARAGON TECHS INC by Paragon Technologies, Inc.

Paragon Technologies Inc

Progyny Inc

Hartshead Resources NL

PERF-GO-GREEN HLDGS INC by PERF Go-Green Holdings, Inc.

PERF Go-Green Holdings Inc

Patriot Gold Corp

Pimco Global StocksPlus & Income Fund Common Shares of Beneficial Interest

PIMCO Global Stocksplus & Income Fund

PUBLICIS GROUPE ACT by Publicis Groupe S.A.

Publicis Groupe SA

PUBLICIS GROUPE ORD

POWER GROUP PROJECTS NEW by Power Group Projects Corp.

Power Group Projects Corp

PARTNERS GRP HLDG ZUG by Partners Group Holding Zug Namen-Akt

Partners Group Holding AG

PGE POLSKA ENERG UNSP/ADR by PGE Polska Energetyczna SA

Polska Grupa Energetyczna SA

PILGRIM PETROLEUM CORP by Pilgrim Petroleum Corp.

Pilgrim Petroleum Corp

First Lithium Minerals Corp

Progressive Corporation (The) Common Stock

Progressive Corp

Paramount Group Inc

Putnam Focused Large Cap Growth ETF

PropertyGuru Group Limited Ordinary Shares

PropertyGuru Group Ltd

PROGRESSIVE GREEN SOL INC by Progressive Green Solutions, Inc.

PEGASUS DIGITAL MOBILITY ACQUISITION CORP CL A ORD SHS

PGT INC COM

PGT INNOVATIONS ORD

PACIFIC GREEN TECHS by Pacific Green Technologies Inc.

Pacific Green Technologies Inc

Pegatron Corp

Prosegur Cash SA

KK PASONA GROUP INC by KK Pasona Group Inc.

Pasona Group Inc

PROMITHIAN GLBL VNTR INC by Promithian Global Ventures, Inc.

Promithian Global Ventures Inc

PGG Wrightson Ltd

Invesco Preferred ETF

Prosper Gold Corp

PELANGIO EXPLORATION by Pelangio Exploration Inc.

Pelangio Exploration Inc

INVSC PREFERRED ETF

Pagaya Technologies Ltd. - Class A Ordinary Shares

Pagaya Technologies Ltd

PATRIOT ENERGY CORP DE by Patriot Energy Corp.

Patriot Energy Corp

Principal Real Estate Income Fund Common Shares of Beneficial Interest

Principal Real Estate Income Fund

PAN GLOBAL RESOURCE INC by Pan Global Resource, Inc.

PROCTER & GAMBLE ORD

News

P&G CFO Says Co Saw Stock-Up Situation As A Quick Run Up Due To The Port Strike Which Didn't Really Have A Material Impact On This Quarter; The Stock-Up Situation Due To Port Strikes Was Very Short-Lived

WIIM

Procter & Gamble shares are trading lower following a Q1 revenue miss.

Procter &amp; Gamble Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PG#NYSE">PG</a>) shares are trading lower after the company reported&nbsp;first-quarter&nbsp;sales of&nbsp;$21.74 billion&nbsp;(-1% Y/Y),&nbsp;missing the analyst <a target="_blank" href="https://www.benzinga.com/pressreleases/24/10/b41399117/p-g-announces-fiscal-year-2025-first-quarter-results" rel="noreferrer noopener">consensus estimate of&nbsp;$21.91 billion</a>.
Organic sales, which exclude the impacts of foreign exchange and acquisitions and divestitures, increased&nbsp;by 2%.
Organic sales growth was driven by a 1% increase in higher pricing and a 1% rise in organic volume, excluding the effects of acquisitions and divestitures.
Sales in the Beauty segment fell&nbsp;5%, and the Baby, Feminine &amp; Family Care segment declined 2%.
Meanwhile, the Grooming segment sales sales remained flat, while Fabric &amp; Home Care grew 1% and Health Care sales increased&nbsp;2%.
Gross profit remained flat&nbsp;at $11.3 billion. The reported gross margin expanded by 10 basis points to&nbsp;52.1%, and the core gross margin was flat year-over-year.
Gains included 170 basis points from productivity savings and 30 basis points from pricing, offset by 90 basis points from higher commodity costs, 60 basis points from unfavorable mix, and 40 basis points from product reinvestments.
Operating margin expanded 30 basis points to&nbsp;26.7% while operating income for the quarter rose 1%&nbsp;to&nbsp;$5.80 billion.
Adjusted EPS of&nbsp;$1.93 <a target="_blank" href="https://www.benzinga.com/earnings" rel="noreferrer noopener">beat the analyst consensus of&nbsp;$1.90.</a>
P&amp;G held&nbsp;$12.16 billion&nbsp;in cash and equivalents as of September 30. Operating cash flow for the quarter was&nbsp;$4.3 billion.
The company returned around $4.4&nbsp;billion&nbsp;of value to shareholders via&nbsp;$2.4 billion&nbsp;in dividend payments and&nbsp;$1.9 billion&nbsp;of share repurchases.
&#8220;We remain committed to our integrated growth strategy of a focused product portfolio of daily use categories where performance drives brand choice, superiority — across product performance, packaging, brand communication, retail execution and consumer and customer value — productivity, constructive disruption and an agile and accountable organization,&#8221; said Board Chairman, President, and CEO Jon Moeller.
Outlook: P&amp;G reaffirmed FY25 guidance for all-in sales growth of&nbsp;2%&nbsp;–&nbsp;4%&nbsp;and <a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">organic sales growth of&nbsp;3%&nbsp;–&nbsp;5%</a>.
This&nbsp;outlook equates to FY25 revenue of&nbsp;$85.72 billion&nbsp;–&nbsp;$87.40 billion&nbsp;(versus an estimate of&nbsp;$86.06 billion) and adjusted EPS of&nbsp;$6.91&nbsp;–<a target="_blank" href="https://www.benzinga.com/news/earnings/24/07/40037468/why-gillette-parent-procter-gamble-shares-are-tumbling-today" rel="noreferrer noopener"> $7.05&nbsp;(vs. consensus of $6.97)</a>.
P&amp;G reaffirmed its outlook for adjusted free cash flow productivity of&nbsp;90%, payment of around&nbsp;$10 billion in dividends and repurchasing&nbsp;$6 billion to&nbsp;$7 billion of common shares in fiscal 2025.
Investors can gain exposure to the stock via&nbsp;iShares U.S. Consumer Staples ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IYK#NYSE">IYK</a>) and Fidelity MSCI COnsumer Staples Index ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FSTA#NYSE">FSTA</a>).
Price Action: PG shares are down 0.81% at $170.88 premarket at the last check Friday.
Photo via Shutterstock
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/10/41397178/procter-gamble-earnings-are-imminent-these-most-accurate-analysts-revise-forecasts-ahead-of-earning" target="_blank" rel="noreferrer noopener">Procter &amp; Gamble Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call</a></li>
</ul>

Earnings

Equities

Large Cap

Guidance

Dividends

Buybacks

Movers

FSTA

iShares Trust Dow Jones USnsumer Goods Sector Index Fund

Procter & Gamble's Mixed Bag Q1: EPS Exceeds Estimates, Reaffirms Growth Outlook & More

Wall Street is priming for a positive start on Friday after the major averages ended narrowly mixed in the previous session. <a href="https://www.benzinga.com/news/earnings/24/10/41391637/netflix-q3-earnings-revenue-beats-eps-tops-q4-guidance-projects-subscriber-boost-from-squid-game-nf">Positive reaction</a> to Netflix, Inc.&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) earnings could provide a lift to the tech space, given earnings news flow from the sector will likely start in earnest next week. Earnings and speeches by Federal Reserve officials could set the tempo for Friday&#8217;s session. China&#8217;s third-quarter GDP rose slightly more than estimates, allaying the fears of traders. Gold continues to make record after record, while oil continues to have a volatile ride amid geopolitical tensions.
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Futures</td>
<td>Performance (+/-)</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>+0.39%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>+0.17%</td>
</tr>
<tr>
<td>Dow</td>
<td>+0.03%</td>
</tr>
<tr>
<td>R2K</td>
<td>+0.46%</td>
</tr>
</tbody>
</table>
</figure>
In premarket trading on Friday,&nbsp;the SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) rose 0.23% to $583.61 and the&nbsp;Invesco QQQ ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) jumped 0.51% to $493.75, according to&nbsp;<a href="https://benzinga.grsm.io/lxquj26b2sag" target="_blank" rel="noreferrer noopener">Benzinga Pro data</a>.
Cues From Last Session:
U.S. stocks closed narrowly mixed as traders digested a batch of mixed economic data as well as a flurry of earnings. After opening higher, the major indices experienced some volatility in the morning, although holding mostly above the unchanged line. 
Stocks gave back most of their gains in late afternoon trading before finishing on a mixed note. 
The Dow Industrials closed at fresh intraday and closing highs, thanks to a positive reaction to Travelers Companies, Inc.&#8217;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TRV#NYSE">TRV</a>) earnings, while the S&amp;P 500 Index hit an intraday high before squandering all the gains and closing marginally lower.
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Index</td>
<td>Performance (+/)</td>
<td>Value</td>
</tr>
<tr>
<td>Nasdaq Composite</td>
<td>+0.04%</td>
<td>18,373.61</td>
</tr>
<tr>
<td>S&amp;P 500 Index</td>
<td>+0.02%</td>
<td>5,841.47</td>
</tr>
<tr>
<td>Dow Industrials</td>
<td>+0.37%</td>
<td>43,239.05</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>-0.25%</td>
<td>2,280.85</td>
</tr>
</tbody>
</table>
</figure>
Insights From Analysts:
After separate reports showed strong September retail sales growth, jobless claims, which fell after Hurricane Helene&#8217;s impact wore off, and a decline in industrial production amid the Boeing Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>) strike, Comerica Chief Economist Bill Adams said, &#8220;The economy is in pretty good shape.&#8221; &#8220;Since consumer spending fuels two-thirds of U.S. demand, the economy can't be doing too bad as long as consumers still have their pocketbooks open,&#8221; he said.
The economist expects the Hurricanes that devastated swathes of the Southeast in late September and early October to be a big drag on releases for October.&nbsp;This will make it difficult to read the underlying trend accurately, he said.
Calling the headwinds temporary, Adams said, &#8220;With the Fed expected to continue lowering interest rates through the turn of the year, credit-sensitive sectors of the economy should perk up in coming quarters, sustaining the economic expansion into 2025.&#8221;
See Also:<a href="https://www.benzinga.com/money/best-strategies-for-futures-trading"> Best Futures Trading Strategies in 2024</a>
Upcoming Economic Data:
<ul>
<li>The Commerce Department will release the housing starts report for September at 8:30 a.m. EDT. Economists, on average, estimate housing starts to come in at a seasonally adjusted annual rate of 1.35 million units, slightly down from the 1.36-million-unit rate in August. Building permits, an indicator of future housing starts may have declined from 1.48 million units to 1.45 million units.</li>
<li>Among the Fed speakers scheduled for the day are:
<ul>
<li>Atlanta Fed president Raphael Bostic: 9:30 a.m. EDT</li>
<li>Minneapolis Fed President Neel Kashkari: 10 a.m. EDT</li>
<li>Fed Governor Christopher Waller is due to speak at 12:10 p.m. EDT.</li>
</ul>
</li>
<li>The Atlanta Fed&#8217;s GDPNow data for the third quarter will be released at 10:30 a.m. EDT.</li>
</ul>
Stocks In Focus:
<ul>
<li>Netflix climbed about 5.75% <a href="https://www.benzinga.com/premarket">in premarket trading</a> following the streaming giant&#8217;s quarterly results.</li>
<li>Among the other stocks moving on earnings are Intuitive Surgical, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) (up nearly 7%), and Western Alliance Bancorporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WAL#NYSE">WAL</a>) (down over 5.25%.</li>
<li>Ally Financial Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALLY#NYSE">ALLY</a>), Autoliv, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALV#NYSE">ALV</a>), Fifth Third Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FITB#NASDAQ">FITB</a>), Procter &amp; Gamble Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PG#NYSE">PG</a>), Regions Financial Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RF#NYSE">RF</a>) and Schlumberger Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLB#NYSE">SLB</a>) and American Express Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AXP#NYSE">AXP</a>) are among the noteworthy <a href="https://www.benzinga.com/calendars/earnings">companies reporting ahead of the market opening</a>.</li>
<li>CVS Health Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVS#NYSE">CVS</a>) fell over 10% after the Wall Street Journal reported that the company is naming longtime executive David Joyner as its new chief, succeeding Karen Lynch.</li>
<li>Coherent Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COHR#NYSE">COHR</a>) fell over 6% on a negative analyst action.</li>
</ul>
Commodities, Bonds And Global Equity Markets:
Crude oil futures pulled back modestly but gold futures gained ground as they scaled a fresh record. Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) added over 1.50% over the past 24 hours and traded just under the $68K mark.
The 10-year U.S. Treasury note yield was little changed at 4.097%.
Asian stocks closed mostly higher, led by China and Hong Kong, which rallied on the back of the Chinese third-quarter GDP data. The Japanese market benefited from the yen&#8217;s weakness. The European Central Bank&#8217;s rate cut also buoyed sentiment.
The European markets also advanced in early trading, although the U.K. market was experiencing some weakness.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41397978/hedge-fund-billionaire-daniel-loeb-bets-on-trump-win-singles-out-this-recent-buy-as">Hedge Fund Billionaire Daniel Loeb Bets On Trump Win, Singles Out This Recent Buy As Having &#8216;Significant Upside Potential&#8217;</a></li>
</ul>
Image Via Shutterstock

Futures

Previews

Economics

Federal Reserve

Pre-Market Outlook

Markets

Trading Ideas

$BTC

ALLY

COHR

FITB

ISRG

NFLX

US Stocks Set To End Week Strong As Netflix Q3 Earnings Boost Optimism, Gold Hits New Highs: What's Driving Sentiment Friday?

Procter & Gamble Reiterates FY25 Outlook: Adj EPS $6.91-$7.05 vs $6.97 Est; Sales $85.720B-$87.401B vs $86.06B Est

Procter &amp; Gamble (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PG#NYSE">PG</a>) reported quarterly earnings of $1.93 per share which beat the analyst consensus estimate of $1.90 by 1.58 percent. This is a 5.46 percent increase over earnings of $1.83 per share from the same period last year. The company reported quarterly sales of $21.737 billion which missed the analyst consensus estimate of $21.914 billion by 0.81 percent. This is a 103.51B percent increase over sales of $21.000 the same period last year.

Earnings Beats

Earnings Misses

Procter & Gamble Q1 2025 Adj. EPS $1.93 Beats $1.90 Estimate, Sales $21.737B Miss $21.914B Estimate

The Procter &amp; Gamble Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PG#NYSE">PG</a>) will release earnings results for its first quarter, before the <a href="https://www.benzinga.com/quote/PG/earnings">opening bell on Friday, Oct. 18.</a>
Analysts expect the Cincinnati, Ohio-based bank to report quarterly earnings at $1.90 per share, up from $1.83 per share in the year-ago period. Procter &amp; Gamble projects to report revenue of $21.91 billion for the recent quarter, compared to $19.78 billion a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On July 30, Procter &amp; Gamble reported fourth-quarter FY24 sales of $20.53 billion (flat Y/Y), missing the analyst consensus estimate of $20.74 billion.
Procter &amp; Gamble shares fell 0.1% to close at $172.28 on Thursday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/TCOM/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/5890a92043eaaa0001d69b01/linda-bolton%20weiser">DA Davidson analyst Linda Bolton Weiser</a> maintained a Neutral rating with a price target of $159 on Oct. 15. This analyst has an accuracy rate of 61%.</li>
<li>Barclays analyst Lauren Lieberman downgraded the stock from Overweight to Equal-Weight with a price target of $163 on Sept. 30. This analyst has an accuracy rate of 63%.</li>
<li>JP Morgan analyst Andrea Teixeira maintained an Overweight rating and increased the price target from $179 to $186 on Sept. 19. This analyst has an accuracy rate of 61%.</li>
<li>TD Cowen analyst Robert Moskow initiated coverage on the stock with a Buy rating and a price target of $189 on July 23. This analyst has an accuracy rate of 65%.</li>
<li>Stifel analyst Mark Astrachan maintained a Hold rating and raised the price target from $157 to $161 on July 22. This analyst has an accuracy rate of 78%.</li>
</ul>
Considering buying PG stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="482" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/18040800/image-158-1024x482.png" alt="" class="wp-image-602127" style="width:665px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/18040800/image-158-1024x482.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/18040800/image-158-300x141.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/18040800/image-158-768x362.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/18040800/image-158.png 1365w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/10/41379749/abbvie-is-doing-very-well-but-jim-cramers-favorite-abbott-laboratories">AbbVie Is Doing &#8216;Very Well&#8217; But Jim Cramer&#8217;s Favorite? Abbott Laboratories</a></li>
</ul>

Price Target

Analyst Ratings

Procter & Gamble Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

The CNN Money Fear and Greed index showed an improvement in the overall market sentiment, while the index remained in the &#8220;Greed&#8221; zone on Thursday.
U.S. stocks settled mostly higher on Thursday, with the Dow Jones index climbing to a new record close following the release of economic data.
U.S. initial jobless claims fell by 19,000 in the week ending Oct. 12. U.S. retail sales rose 0.4% month-over-month in September compared to a 0.1% increase in August and higher than market estimates of a 0.3% rise. The Philadelphia Fed Manufacturing Index climbed to 10.3 in October compared to 1.7 in September and topping market estimates of 3.
Taiwan Semiconductor Manufacturing Company Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>) shares jumped around 9.8% on Thursday following better-than-expected third-quarter earnings and strong fourth-quarter guidance
Most sectors on the S&amp;P 500 closed on a negative note, with utilities, communication services, and real estate stocks recording the biggest losses on Thursday. However, energy and information technology stocks bucked the overall market trend, closing the session higher.
The Dow Jones closed higher by around 161 points to 43,239.05 on Thursday. The S&amp;P 500 slipped 0.02% to 5,841.47, while the Nasdaq Composite rose 0.04% at 18,373.61 during Thursday's session.
Investors are awaiting earnings results from American Express Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AXP#NYSE">AXP</a>), The Procter &amp; Gamble Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PG#NYSE">PG</a>), and Schlumberger Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLB#NYSE">SLB</a>) today.
What is CNN Business Fear &amp; Greed Index?
At a current reading of 71.5, the index remained in the &#8220;Greed&#8221; zone on Thursday, versus a prior reading of 69.5.
The Fear &amp; Greed Index is a measure of the current market sentiment. It is based on the premise that higher fear exerts pressure on stock prices, while higher greed has the opposite effect. The index is calculated based on seven equal-weighted indicators. The index ranges from 0 to 100, where 0 represents maximum fear and 100 signals maximum greediness.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/10/41379749/abbvie-is-doing-very-well-but-jim-cramers-favorite-abbott-laboratories">AbbVie Is Doing &#8216;Very Well&#8217; But Jim Cramer&#8217;s Favorite? Abbott Laboratories</a></li>
</ul>
Photo courtesy: Shutterstock

TSMC, Strong Economic Data Push Dow To Fresh Record High: Investor Sentiment Improves, Fear Index Remains In 'Greed' Zone

With U.S. stock futures trading mixed this morning on Friday, some of the stocks that may grab investor focus today are as follows:
<ul>
<li>Wall Street expects American Express Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AXP#NYSE">AXP</a>) to report quarterly earnings at $3.28 per share on revenue of $16.67 billion before the opening bell, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>. American Express shares gained 1.8% to $290.91 in after-hours trading.</li>
<li>Netflix Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) reported stronger-than-expected third-quarter financial results, posting revenue of $9.825 billion, up 15% year-over-year, versus market estimates of $9.769 billion. The company ended the third quarter with 282.72 million global paid subscribers, up 14.4% year-over-year. Netflix shares climbed 5.1% to $722.35 in the after-hours trading session.</li>
<li>Analysts are expecting The Procter &amp; Gamble Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PG#NYSE">PG</a>) to post quarterly earnings at $1.90 per share on revenue of $21.91 billion. The company will release earnings before the markets open. Procter &amp; Gamble shares gained 0.1% to $172.50 in after-hours trading.</li>
</ul>
Check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>
<ul>
<li>Intuitive Surgical, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) posted better-than-expected third-quarter financial results. The company also said it obtained regulatory clearance in South Korea for the da Vinci 5 surgical system in October. Intuitive Surgical shares climbed 6.1% to $502.80 in the after-hours trading session.</li>
<li>Analysts expect Schlumberger Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLB#NYSE">SLB</a>) to report quarterly earnings at 88 cents per share on revenue of $9.25 billion before the opening bell. SLB shares rose 0.4% to $44.16 in after-hours trading.</li>
</ul>
Check This Out: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/10/41379749/abbvie-is-doing-very-well-but-jim-cramers-favorite-abbott-laboratories">AbbVie Is Doing &#8216;Very Well&#8217; But Jim Cramer&#8217;s Favorite? Abbott Laboratories</a></li>
</ul>
Photo courtesy: Shutterstock

Netflix, American Express And 3 Stocks To Watch Heading Into Friday

In today's rapidly changing and highly competitive business world, it is vital for investors and industry enthusiasts to carefully assess companies. In this article, we will perform a comprehensive industry comparison, evaluating Procter &amp; Gamble (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PG#NYSE">PG</a>) against its key competitors in the Household Products industry. By analyzing important financial metrics, market position, and growth prospects, we aim to provide valuable insights for investors and shed light on company's performance within the industry.
<h3>Procter &amp; Gamble Background</h3>
Since its founding in 1837, Procter &amp; Gamble has become one of the world's largest consumer product manufacturers, generating more than $80 billion in annual sales. It operates with a lineup of leading brands, including more than 20 that generate north of $1 billion each in annual global sales, such as Tide laundry detergent, Charmin toilet paper, Pantene shampoo, and Pampers diapers. Sales outside its home turf represent more than half of the firm's consolidated total.
<table>
<thead>
<tr>
<th>Company</th>
<th>P/E</th>
<th>P/B</th>
<th>P/S</th>
<th>ROE</th>
<th>EBITDA (in billions)</th>
<th>Gross Profit (in billions)</th>
<th>Revenue Growth</th>
</tr>
</thead>
<tbody>
<tr>
<td>Procter &amp; Gamble Co</td>
<td>28.63</td>
<td>8.18</td>
<td>5.07</td>
<td>6.2%</td>
<td>$4.85</td>
<td>$10.18</td>
<td>-0.1%</td>
</tr>
<tr>
<td>Colgate-Palmolive Co</td>
<td>29.50</td>
<td>672.20</td>
<td>4.18</td>
<td>414.16%</td>
<td>$1.25</td>
<td>$3.07</td>
<td>4.89%</td>
</tr>
<tr>
<td>Kimberly-Clark Corp</td>
<td>21.59</td>
<td>43.27</td>
<td>2.44</td>
<td>49.91%</td>
<td>$0.84</td>
<td>$1.81</td>
<td>-2.05%</td>
</tr>
<tr>
<td>Church &amp; Dwight Co Inc</td>
<td>32.30</td>
<td>5.95</td>
<td>4.31</td>
<td>5.79%</td>
<td>$0.4</td>
<td>$0.71</td>
<td>3.92%</td>
</tr>
<tr>
<td>Clorox Co</td>
<td>72.64</td>
<td>61.62</td>
<td>2.88</td>
<td>103.1%</td>
<td>$0.35</td>
<td>$0.88</td>
<td>-5.75%</td>
</tr>
<tr>
<td>Reynolds Consumer Products Inc</td>
<td>17.77</td>
<td>3.13</td>
<td>1.72</td>
<td>4.82%</td>
<td>$0.17</td>
<td>$0.26</td>
<td>-1.06%</td>
</tr>
<tr>
<td>WD-40 Co</td>
<td>51.80</td>
<td>16.07</td>
<td>6.23</td>
<td>9.02%</td>
<td>$0.03</td>
<td>$0.08</td>
<td>9.4%</td>
</tr>
<tr>
<td>Spectrum Brands Holdings Inc</td>
<td>23.53</td>
<td>1.24</td>
<td>1.24</td>
<td>0.28%</td>
<td>$0.08</td>
<td>$0.3</td>
<td>5.97%</td>
</tr>
<tr>
<td>Central Garden &amp; Pet Co</td>
<td>14.17</td>
<td>1.30</td>
<td>0.63</td>
<td>5.14%</td>
<td>$0.14</td>
<td>$0.32</td>
<td>-2.63%</td>
</tr>
<tr>
<td>Energizer Holdings Inc</td>
<td>230.57</td>
<td>18.78</td>
<td>0.80</td>
<td>-27.84%</td>
<td>$0.01</td>
<td>$0.28</td>
<td>0.29%</td>
</tr>
<tr>
<td>Oil-Dri Corp of America</td>
<td>12.82</td>
<td>2.41</td>
<td>1.41</td>
<td>3.08%</td>
<td>$0.02</td>
<td>$0.03</td>
<td>5.88%</td>
</tr>
<tr>
<td>Average</td>
<td>50.67</td>
<td>82.6</td>
<td>2.58</td>
<td>56.75%</td>
<td>$0.33</td>
<td>$0.77</td>
<td>1.89%</td>
</tr>
</tbody>
</table>
<style>
 table {
 width: 100%;
 border-collapse: collapse;
 font-family: Arial, sans-serif;
 font-size: 14px;
 }

 th, td {
 padding: 8px;
 text-align: left;
 }

 th {
 background-color: #293a5a;
 color: #fff;
 text-align: left;
 }

 tr:nth-child(even) {
 background-color: #f2f4f8;
 }

 tr:hover {
 background-color: #e1e4ea;
 }

 td:nth-child(3), td:nth-child(5) {
 text-align: left;
 }

 .dividend-amount {
 font-weight: bold;
 color: #0d6efd;
 }

 .dividend-frequency {
 font-size: 12px;
 color: #6c757d;
 }
 </style>After a detailed analysis of Procter &amp; Gamble, the following trends become apparent: 
<ul>
<li>
With a Price to Earnings ratio of 28.63, which is 0.57x less than the industry average, the stock shows potential for growth at a reasonable price, making it an interesting consideration for market participants.
</li>
<li>
Considering a Price to Book ratio of 8.18, which is well below the industry average by 0.1x, the stock may be undervalued based on its book value compared to its peers.
</li>
<li>
The Price to Sales ratio of 5.07, which is 1.97x the industry average, suggests the stock could potentially be overvalued in relation to its sales performance compared to its peers.
</li>
<li>
The company has a lower Return on Equity (ROE) of 6.2%, which is 50.55% below the industry average. This indicates potential inefficiency in utilizing equity to generate profits, which could be attributed to various factors.
</li>
<li>
Compared to its industry, the company has higher Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) of $4.85 Billion, which is 14.7x above the industry average, indicating stronger profitability and robust cash flow generation.
</li>
<li>
With higher gross profit of $10.18 Billion, which indicates 13.22x above the industry average, the company demonstrates stronger profitability and higher earnings from its core operations.
</li>
<li>
The company's revenue growth of -0.1% is significantly lower compared to the industry average of 1.89%. This indicates a potential fall in the company's sales performance.
</li>
</ul>
<h3>Debt To Equity Ratio</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1729177228_0.png" alt="debt to equity" />
The debt-to-equity (D/E) ratio is a measure that indicates the level of debt a company has taken on relative to the value of its assets net of liabilities.
Considering the debt-to-equity ratio in industry comparisons allows for a concise evaluation of a company's financial health and risk profile, aiding in informed decision-making.
By evaluating Procter &amp; Gamble against its top 4 peers in terms of the Debt-to-Equity ratio, the following observations arise:
<ul>
<li>
Procter &amp; Gamble demonstrates a stronger financial position compared to its top 4 peers in the sector.
</li>
<li>
With a lower debt-to-equity ratio of 0.67, the company relies less on debt financing and maintains a healthier balance between debt and equity, which can be viewed positively by investors.
</li>
</ul>
<h3>Key Takeaways</h3>
For Procter &amp; Gamble, the PE and PB ratios are low compared to peers, indicating potential undervaluation. However, the high PS ratio suggests overvaluation based on revenue. The low ROE and revenue growth, along with high EBITDA and gross profit, may indicate operational efficiency but limited growth potential within the Household Products industry.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Comparative Study: Procter &amp; Gamble And Industry Competitors In Household Products Industry

Procter &amp; Gamble (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PG#NYSE">PG</a>) is set to give its latest quarterly earnings report on Friday, 2024-10-18. Here's what investors need to know before the announcement.
Analysts estimate that Procter &amp; Gamble will report an earnings per share (EPS) of $1.90. 
Investors in Procter &amp; Gamble are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
<h3>Performance in Previous Earnings</h3>
In the previous earnings release, the company beat EPS by $0.03, leading to a 0.58% drop in the share price the following trading session.
Here's a look at Procter &amp; Gamble's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>1.37</td>
<td>1.30</td>
<td>1.70</td>
<td>1.71</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>1.40</td>
<td>1.52</td>
<td>1.84</td>
<td>1.83</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-1.0%</td>
<td>1.0%</td>
<td>-1.0%</td>
<td>-1.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2024/1729173622_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of Procter &amp; Gamble were trading at $172.38 as of October 16. Over the last 52-week period, shares are up 16.58%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<h3>Analyst Opinions on Procter &amp; Gamble</h3>
For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Procter &amp; Gamble.
Analysts have provided Procter &amp; Gamble with 14 ratings, resulting in a consensus rating of Neutral. The average one-year price target stands at $172.64, suggesting a potential 0.15% upside.
<h3>Peer Ratings Overview</h3>
In this analysis, we delve into the analyst ratings and average 1-year price targets of Colgate-Palmolive, Kimberly-Clark and Church &amp; Dwight Co, three key industry players, offering insights into their relative performance expectations and market positioning.
<ul>
<li>The consensus outlook from analysts is an Buy trajectory for Colgate-Palmolive, with an average 1-year price target of $107.07, indicating a potential 37.89% downside.</li>
<li>Analysts currently favor an Neutral trajectory for Kimberly-Clark, with an average 1-year price target of $145.0, suggesting a potential 15.88% downside.</li>
<li>Church &amp; Dwight Co is maintaining an Underperform status according to analysts, with an average 1-year price target of $101.71, indicating a potential 41.0% downside.</li>
</ul>
<h3>Analysis Summary for Peers</h3>
The peer analysis summary offers a detailed examination of key metrics for Colgate-Palmolive, Kimberly-Clark and Church &amp; Dwight Co, providing valuable insights into their respective standings within the industry and their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Procter &amp; Gamble</td>
<td>Neutral</td>
<td>-0.10%</td>
<td>$10.18B</td>
<td>6.20%</td>
</tr>
<tr>
<td>Colgate-Palmolive</td>
<td>Buy</td>
<td>4.89%</td>
<td>$3.07B</td>
<td>414.16%</td>
</tr>
<tr>
<td>Kimberly-Clark</td>
<td>Neutral</td>
<td>-2.05%</td>
<td>$1.81B</td>
<td>49.91%</td>
</tr>
<tr>
<td>Church &amp; Dwight Co</td>
<td>Underperform</td>
<td>3.92%</td>
<td>$712.10M</td>
<td>5.79%</td>
</tr>
</tbody>
</table>

Key Takeaway:
Procter &amp; Gamble ranks at the bottom for Revenue Growth among its peers. It is in the middle for Gross Profit. For Return on Equity, it is at the bottom.
<h3>Delving into Procter &amp; Gamble's Background</h3>
Since its founding in 1837, Procter &amp; Gamble has become one of the world's largest consumer product manufacturers, generating more than $80 billion in annual sales. It operates with a lineup of leading brands, including more than 20 that generate north of $1 billion each in annual global sales, such as Tide laundry detergent, Charmin toilet paper, Pantene shampoo, and Pampers diapers. Sales outside its home turf represent more than half of the firm's consolidated total.
<h3>Key Indicators: Procter &amp; Gamble's Financial Health</h3>
Market Capitalization Analysis: With an elevated market capitalization, the company stands out above industry averages, showcasing substantial size and market acknowledgment.
Negative Revenue Trend: Examining Procter &amp; Gamble's financials over 3 months reveals challenges. As of 30 June, 2024, the company experienced a decline of approximately -0.1% in revenue growth, reflecting a decrease in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Consumer Staples sector.
Net Margin: Procter &amp; Gamble's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 14.91%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Procter &amp; Gamble's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of 6.2%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): Procter &amp; Gamble's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 2.53% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: Procter &amp; Gamble's debt-to-equity ratio is below the industry average. With a ratio of 0.67, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<a href="https://www.benzinga.com/quote/PG/earnings">To track all earnings releases for Procter &amp; Gamble visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Examining the Future: Procter & Gamble's Earnings Outlook

Throughout the last three months, 15 analysts have evaluated Procter &amp; Gamble (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PG#NYSE">PG</a>), offering a diverse set of opinions from bullish to bearish.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">6</td>
<td style="text-align: right;">7</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for Procter &amp; Gamble, revealing an average target of $173.33, a high estimate of $190.00, and a low estimate of $159.00. Surpassing the previous average price target of $169.91, the current average has increased by 2.01%.
<img src="https://www.benzinga.com/files/images/story/2024/1729011686_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Procter &amp; Gamble. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Linda Bolton Weiser</td>
<td>DA Davidson</td>
<td>Maintains</td>
<td>Neutral</td>
<td>$159.00</td>
<td>$159.00</td>
</tr>
<tr>
<td>Linda Bolton Weiser</td>
<td>DA Davidson</td>
<td>Announces</td>
<td>Neutral</td>
<td>$159.00</td>
<td>-</td>
</tr>
<tr>
<td>Lauren Lieberman</td>
<td>Barclays</td>
<td>Maintains</td>
<td>Equal-Weight</td>
<td>$163.00</td>
<td>$163.00</td>
</tr>
<tr>
<td>Korinne Wolfmeyer</td>
<td>Piper Sandler</td>
<td>Announces</td>
<td>Neutral</td>
<td>$174.00</td>
<td>-</td>
</tr>
<tr>
<td>Andrea Teixeira</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$186.00</td>
<td>$179.00</td>
</tr>
<tr>
<td>Michael Pohn</td>
<td>DZ Bank</td>
<td>Announces</td>
<td>Buy</td>
<td>$190.00</td>
<td>-</td>
</tr>
<tr>
<td>Lauren Lieberman</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$163.00</td>
<td>$174.00</td>
</tr>
<tr>
<td>Andrea Teixeira</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$179.00</td>
<td>$181.00</td>
</tr>
<tr>
<td>Nik Modi</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Sector Perform</td>
<td>$164.00</td>
<td>$157.00</td>
</tr>
<tr>
<td>Kaumil Gajrawala</td>
<td>Jefferies</td>
<td>Lowers</td>
<td>Hold</td>
<td>$175.00</td>
<td>$182.00</td>
</tr>
<tr>
<td>Robert Moskow</td>
<td>TD Cowen</td>
<td>Announces</td>
<td>Buy</td>
<td>$189.00</td>
<td>-</td>
</tr>
<tr>
<td>Andrea Teixeira</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$181.00</td>
<td>$170.00</td>
</tr>
<tr>
<td>Mark Astrachan</td>
<td>Stifel</td>
<td>Raises</td>
<td>Hold</td>
<td>$161.00</td>
<td>$157.00</td>
</tr>
<tr>
<td>Lauren Lieberman</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$174.00</td>
<td>$170.00</td>
</tr>
<tr>
<td>Robert Ottenstein</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>Outperform</td>
<td>$183.00</td>
<td>$177.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Procter &amp; Gamble. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Procter &amp; Gamble compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of Procter &amp; Gamble's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Procter &amp; Gamble's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/PG/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Procter &amp; Gamble analyst ratings.</a>
<h2>Get to Know Procter &amp; Gamble Better</h2>
Since its founding in 1837, Procter &amp; Gamble has become one of the world's largest consumer product manufacturers, generating more than $80 billion in annual sales. It operates with a lineup of leading brands, including more than 20 that generate north of $1 billion each in annual global sales, such as Tide laundry detergent, Charmin toilet paper, Pantene shampoo, and Pampers diapers. Sales outside its home turf represent more than half of the firm's consolidated total.
<h3>Procter &amp; Gamble: Financial Performance Dissected</h3>
Market Capitalization: Boasting an elevated market capitalization, the company surpasses industry averages. This signals substantial size and strong market recognition.
Negative Revenue Trend: Examining Procter &amp; Gamble's financials over 3 months reveals challenges. As of 30 June, 2024, the company experienced a decline of approximately -0.1% in revenue growth, reflecting a decrease in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Consumer Staples sector.
Net Margin: Procter &amp; Gamble's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 14.91% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): Procter &amp; Gamble's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of 6.2%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 2.53%, the company showcases effective utilization of assets.
Debt Management: With a below-average debt-to-equity ratio of 0.67, Procter &amp; Gamble adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Forecasting The Future: 15 Analyst Projections For Procter & Gamble

DA Davidson analyst Linda Bolton Weiser maintains Procter &amp; Gamble (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PG#NYSE">PG</a>) with a Neutral and maintains $159 price target.

DA Davidson Maintains Neutral on Procter & Gamble, Maintains $159 Price Target

DA Davidson analyst Linda Bolton Weiser initiates coverage on Procter &amp; Gamble (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PG#NYSE">PG</a>) with a Neutral rating and announces Price Target of $159.

Initiation

DA Davidson Initiates Coverage On Procter & Gamble with Neutral Rating, Announces Price Target of $159

Financial giants have made a conspicuous bearish move on Procter &amp; Gamble. Our analysis of options history for Procter &amp; Gamble (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PG#NYSE">PG</a>) revealed 8 unusual trades.
Delving into the details, we found 37% of traders were bullish, while 62% showed bearish tendencies. Out of all the trades we spotted, 2 were puts, with a value of $64,067, and 6 were calls, valued at $265,953.
<h3>Predicted Price Range</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $150.0 and $175.0 for Procter &amp; Gamble, spanning the last three months.
<h3>Analyzing Volume &amp; Open Interest</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Procter &amp; Gamble's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Procter &amp; Gamble's significant trades, within a strike price range of $150.0 to $175.0, over the past month.
<h3>Procter &amp; Gamble Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1728492345_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>PG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$20.85</td>
<td>$20.5</td>
<td>$20.8</td>
<td>$150.00</td>
<td>$66.5K</td>
<td>89</td>
<td>34</td>
</tr>
<tr>
<td>PG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>10/25/24</td>
<td>$0.97</td>
<td>$0.96</td>
<td>$0.96</td>
<td>$175.00</td>
<td>$65.2K</td>
<td>532</td>
<td>879</td>
</tr>
<tr>
<td>PG</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$5.45</td>
<td>$5.3</td>
<td>$5.35</td>
<td>$170.00</td>
<td>$39.0K</td>
<td>2.2K</td>
<td>161</td>
</tr>
<tr>
<td>PG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>10/25/24</td>
<td>$1.03</td>
<td>$0.94</td>
<td>$0.94</td>
<td>$175.00</td>
<td>$37.4K</td>
<td>532</td>
<td>2.1K</td>
</tr>
<tr>
<td>PG</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$2.33</td>
<td>$2.32</td>
<td>$2.32</td>
<td>$150.00</td>
<td>$36.4K</td>
<td>143</td>
<td>638</td>
</tr>
</tbody>
</table>

<h3>About Procter &amp; Gamble</h3>
Since its founding in 1837, Procter &amp; Gamble has become one of the world's largest consumer product manufacturers, generating more than $80 billion in annual sales. It operates with a lineup of leading brands, including more than 20 that generate north of $1 billion each in annual global sales, such as Tide laundry detergent, Charmin toilet paper, Pantene shampoo, and Pampers diapers. Sales outside its home turf represent more than half of the firm's consolidated total.
After a thorough review of the options trading surrounding Procter &amp; Gamble, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Current Position of Procter &amp; Gamble</h3>
<ul>
<li>Currently trading with a volume of 3,925,689, the PG's price is up by 0.59%, now at $169.15. </li>
<li>RSI readings suggest the stock is currently is currently neutral between overbought and oversold.</li>
<li>Anticipated earnings release is in 9 days.</li>
</ul>
<h3>Expert Opinions on Procter &amp; Gamble</h3>
3 market experts have recently issued ratings for this stock, with a consensus target price of $174.33333333333334.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Maintaining their stance, an analyst from JP Morgan continues to hold a Overweight rating for Procter &amp; Gamble, targeting a price of $186. 
&#x2A; Reflecting concerns, an analyst from Piper Sandler lowers its rating to Neutral with a new price target of $174. 
&#x2A; In a cautious move, an analyst from Barclays downgraded its rating to Equal-Weight, setting a price target of $163. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Procter &amp; Gamble, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

Options

Market Whales and Their Recent Bets on Procter & Gamble Options

Goldman Sachs analyst Bonnie Herzog lowered Procter &amp; Gamble Company&#8217;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PG#NYSE">PG</a>) <a target="_blank" href="https://www.benzinga.com/quote/pg/analyst-ratings" rel="noreferrer noopener">first-quarter estimates to reflect softer end markets</a>.
Consequently, the analyst cut the price target to $164 (from $165), with a Neutral rating.
The analyst writes that while scanner trends show resilience for the company and continued growth in the U.S., challenges in international markets like the Middle East and China may offset this.
The analyst anticipates no recovery for SK-II until late 2024, when negative sentiment toward Japanese brands begins to ease.
Herzog is lowering first-quarter estimates, expecting organic sales growth of around 2%, which is expected to be mostly neutralized by FX translation headwinds, leading to flat net sales growth for the quarter.
Moreover, the analyst anticipates slight gross margin expansion supporting 4.7% year-over-year EPS growth to $1.91, down from $1.96 earlier.
The analyst says that due to challenges in Procter &amp; Gamble&#8217;s end markets and a slowdown to 2% growth in fourth-quarter, investor expectations have shifted to the lower end of PG&#8217;s FY25 organic sales growth guidance of 3%-5% (vs. GS/consensus estimates of 3.5% and 3.6%).
Coupled with productivity gains, this should yield over 5% EPS CAGR from FY24 to FY27, slightly below the previous 6.5% CAGR, adds the analyst.
Overall, the analyst remains cautious about the stock, especially as PG's organic sales growth has decelerated over the past few quarters while trading at elevated multiples.
Investors can gain exposure to the stock via&nbsp;iShares U.S. Consumer Staples ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IYK#NYSE">IYK</a>) and Vanguard Consumer Staples ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VDC#NYSE">VDC</a>)
Price Action: PG shares are down 0.93% at $167.31 at the last check Monday.
Image from Shutterstock
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/24/09/40820516/metals-in-tampons-fda-initiates-new-safety-measures-and-testing" target="_blank" rel="noreferrer noopener">Metals in Tampons: FDA Initiates New Safety Measures and Testing</a></li>
</ul>

Analyst Color

Reiteration

Procter & Gamble Q1 Forecast Cut As Global Challenges Persist, Goldman Sachs Warns

In the dynamic and cutthroat world of business, conducting thorough company analysis is essential for investors and industry experts. In this article, we will undertake a comprehensive industry comparison, evaluating Procter &amp; Gamble (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PG#NYSE">PG</a>) and its primary competitors in the Household Products industry. By closely examining key financial metrics, market position, and growth prospects, our aim is to provide valuable insights for investors and shed light on company's performance within the industry.
<h3>Procter &amp; Gamble Background</h3>
Since its founding in 1837, Procter &amp; Gamble has become one of the world's largest consumer product manufacturers, generating more than $80 billion in annual sales. It operates with a lineup of leading brands, including more than 20 that generate north of $1 billion each in annual global sales, such as Tide laundry detergent, Charmin toilet paper, Pantene shampoo, and Pampers diapers. Sales outside its home turf represent more than half of the firm's consolidated total.
<table>
<thead>
<tr>
<th>Company</th>
<th>P/E</th>
<th>P/B</th>
<th>P/S</th>
<th>ROE</th>
<th>EBITDA (in billions)</th>
<th>Gross Profit (in billions)</th>
<th>Revenue Growth</th>
</tr>
</thead>
<tbody>
<tr>
<td>Procter &amp; Gamble Co</td>
<td>28.56</td>
<td>8.16</td>
<td>5.06</td>
<td>6.2%</td>
<td>$4.85</td>
<td>$10.18</td>
<td>-0.1%</td>
</tr>
<tr>
<td>Colgate-Palmolive Co</td>
<td>29.76</td>
<td>677.98</td>
<td>4.22</td>
<td>414.16%</td>
<td>$1.25</td>
<td>$3.07</td>
<td>4.89%</td>
</tr>
<tr>
<td>Kimberly-Clark Corp</td>
<td>20.97</td>
<td>42.03</td>
<td>2.37</td>
<td>49.91%</td>
<td>$0.84</td>
<td>$1.81</td>
<td>-2.05%</td>
</tr>
<tr>
<td>Church &amp; Dwight Co Inc</td>
<td>31.87</td>
<td>5.87</td>
<td>4.25</td>
<td>5.79%</td>
<td>$0.4</td>
<td>$0.71</td>
<td>3.92%</td>
</tr>
<tr>
<td>Clorox Co</td>
<td>73.20</td>
<td>62.20</td>
<td>2.90</td>
<td>103.1%</td>
<td>$0.35</td>
<td>$0.88</td>
<td>-5.75%</td>
</tr>
<tr>
<td>Reynolds Consumer Products Inc</td>
<td>17.63</td>
<td>3.10</td>
<td>1.71</td>
<td>4.82%</td>
<td>$0.17</td>
<td>$0.26</td>
<td>-1.06%</td>
</tr>
<tr>
<td>WD-40 Co</td>
<td>50.84</td>
<td>15.78</td>
<td>6.11</td>
<td>9.02%</td>
<td>$0.03</td>
<td>$0.08</td>
<td>9.4%</td>
</tr>
<tr>
<td>Spectrum Brands Holdings Inc</td>
<td>23.66</td>
<td>1.25</td>
<td>1.24</td>
<td>0.28%</td>
<td>$0.08</td>
<td>$0.3</td>
<td>5.97%</td>
</tr>
<tr>
<td>Central Garden &amp; Pet Co</td>
<td>13.84</td>
<td>1.27</td>
<td>0.61</td>
<td>5.14%</td>
<td>$0.14</td>
<td>$0.32</td>
<td>-2.63%</td>
</tr>
<tr>
<td>Energizer Holdings Inc</td>
<td>226.50</td>
<td>18.45</td>
<td>0.79</td>
<td>-27.84%</td>
<td>$0.01</td>
<td>$0.28</td>
<td>0.29%</td>
</tr>
<tr>
<td>Oil-Dri Corp of America</td>
<td>11.54</td>
<td>2.41</td>
<td>1.58</td>
<td>3.9%</td>
<td>$0.02</td>
<td>$0.03</td>
<td>1.28%</td>
</tr>
<tr>
<td>Average</td>
<td>49.98</td>
<td>83.03</td>
<td>2.58</td>
<td>56.83%</td>
<td>$0.33</td>
<td>$0.77</td>
<td>1.43%</td>
</tr>
</tbody>
</table>
<style>
 table {
 width: 100%;
 border-collapse: collapse;
 font-family: Arial, sans-serif;
 font-size: 14px;
 }

 th, td {
 padding: 8px;
 text-align: left;
 }

 th {
 background-color: #293a5a;
 color: #fff;
 text-align: left;
 }

 tr:nth-child(even) {
 background-color: #f2f4f8;
 }

 tr:hover {
 background-color: #e1e4ea;
 }

 td:nth-child(3), td:nth-child(5) {
 text-align: left;
 }

 .dividend-amount {
 font-weight: bold;
 color: #0d6efd;
 }

 .dividend-frequency {
 font-size: 12px;
 color: #6c757d;
 }
 </style>After a detailed analysis of Procter &amp; Gamble, the following trends become apparent: 
<ul>
<li>
A Price to Earnings ratio of 28.56 significantly below the industry average by 0.57x suggests undervaluation. This can make the stock appealing for those seeking growth.
</li>
<li>
The current Price to Book ratio of 8.16, which is 0.1x the industry average, is substantially lower than the industry average, indicating potential undervaluation.
</li>
<li>
The Price to Sales ratio of 5.06, which is 1.96x the industry average, suggests the stock could potentially be overvalued in relation to its sales performance compared to its peers.
</li>
<li>
The Return on Equity (ROE) of 6.2% is 50.63% below the industry average, suggesting potential inefficiency in utilizing equity to generate profits.
</li>
<li>
The Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) of $4.85 Billion is 14.7x above the industry average, highlighting stronger profitability and robust cash flow generation.
</li>
<li>
With higher gross profit of $10.18 Billion, which indicates 13.22x above the industry average, the company demonstrates stronger profitability and higher earnings from its core operations.
</li>
<li>
The company's revenue growth of -0.1% is significantly below the industry average of 1.43%. This suggests a potential struggle in generating increased sales volume.
</li>
</ul>
<h3>Debt To Equity Ratio</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727967628_0.png" alt="debt to equity" />
The debt-to-equity (D/E) ratio gauges the extent to which a company has financed its operations through debt relative to equity.
Considering the debt-to-equity ratio in industry comparisons allows for a concise evaluation of a company's financial health and risk profile, aiding in informed decision-making.
In light of the Debt-to-Equity ratio, a comparison between Procter &amp; Gamble and its top 4 peers reveals the following information:
<ul>
<li>
Among its top 4 peers, Procter &amp; Gamble has a stronger financial position with a lower debt-to-equity ratio of 0.67.
</li>
<li>
This indicates that the company relies less on debt financing and maintains a more favorable balance between debt and equity, which can be viewed positively by investors.
</li>
</ul>
<h3>Key Takeaways</h3>
For Procter &amp; Gamble, the PE and PB ratios are low compared to peers in the Household Products industry, indicating potential undervaluation. However, the high PS ratio suggests that the stock may be overvalued based on revenue. In terms of profitability, the low ROE and revenue growth, along with high EBITDA and gross profit, indicate mixed performance compared to industry peers.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Assessing Procter &amp; Gamble's Performance Against Competitors In Household Products Industry

Barclays analyst Lauren Lieberman downgrades Procter &amp; Gamble (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PG#NYSE">PG</a>) from Overweight to Equal-Weight and maintains the price target from $163 to $163.

Downgrades

Barclays Downgrades Procter & Gamble to Equal-Weight, Maintains Price Target to $163

It&#8217;s a week since the Intelligent Livermore ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIVR#NASDAQ">LIVR</a>), an <a href="https://www.benzinga.com/money/best-etfs">exchange-traded fund </a>that aims to mimic the investment philosophies of prominent investors, debuted, and here&#8217;s a look at how the financial asset has fared and the opportunity it presents for investors.
LIVR&#8217;s Origin? For the unversed, LIVR is the first instrument launched by investment firm Intelligent Alpha floated by Doug Clinton, co-founder and Managing Partner at Deepwater Asset Management. Intelligent Alpha aims to use artificial intelligence technology to zero in on portfolio assets, tapping specifically into three of the most popular large-language models such as OpenAI&#8217;s ChatGPT, Anthropic&#8217;s Claude and Alphabet, Inc.&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) Gemini. 
LIVR has been named after <a href="https://www.benzinga.com/general/11/07/1808727/celebrating-the-life-of-jesse-livermore">famed 20th-century investor Jesse Livermore </a>who is considered the pioneer of day trading. To start with, the LIVR portfolio will focus on opportunities in AI, Latin American equities, Asian equities, renewables and energy, and defensive stocks as selected by the AI investment committee, the firm said.
&#8220;My experience investing in emerging technologies over the last decade makes me believe that large-language AI models will drive a trillion-dollar shift in the asset management industry from traditional passive and active portfolios to AI-powered portfolios," said Clinton in a statement.
The ETF created a unique investment strategy by drawing upon inputs from financial information, public letters, interviews and statements from finance legends such as Warren Buffett and hedge fund managers such as Stanley Druckenmiller and David Tepper, Clinton reportedly <a href="https://fortune.com/2024/09/19/etf-warren-buffett-druckenmiller-tepper-finance-investors/">told</a> Fortune. 
&#8220;They can sort of replicate or pretend to be any investor. That's one of the superpowers of AI,&#8221; he reportedly said. &#8220;You could have it be a super aggressive growth investor, or you could have it be a super value conscious Buffett acolyte.&#8221;
See Also: <a href="https://www.benzinga.com/money/best-artificial-intelligence-stocks">Best AI Stocks</a>
LIVR has an expense ratio of 0.69% and it has $13.8 million in assets under management. The top five holdings of the ETF and each of their portfolio weightings are:
<ul>
<li>PDD Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PDD#NASDAQ">PDD</a>): 4.60%</li>
<li>Meta Platforms, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>): 4.55%</li>
<li>Nvidia Corp. (NASDAQ: NVDA): 4.51%</li>
<li>Taiwan Semiconductor Management Co. Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>): 4.41%</li>
<li>Procter &amp; Gamble Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PG#NYSE">PG</a>): 2.96%</li>
</ul>
Performance: LIVR began trading on the Nasdaq on Wednesday, Sept. 18, starting the session at a net asset value of $25.21 before ending down about 0.6% at $25.05. The ETF largely remained rang-bound around the $25 level and ended Tuesday&#8217;s session up 2.07% at $26.08. Over the past week, the ETF has gained 4.1%, outperforming the Invesco QQQ Trust (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) and the SPDR S&amp;P 500 ETF Trust (NYSE SPY), which are up a little over 3% and 2%, respectively.
During the same time, the Global X Artificial Intelligence &amp; Technology ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIQ#NASDAQ">AIQ</a>) has added a comparable 4.6%.
It&#8217;s still in the early days to assess the success of the ETF. That said, the heavy weighting of AI-levered stocks could keep it on track to perform in line with these stocks. Since the AI bubble is seen to last for three to five years, LIVR could make hay while the sun shines. That said, the Federal Reserve&#8217;s interest rate cut is widely expected to apply brakes on the tech rally.
On Tuesday, LIVR added 2.07% before ending at $26.08, according to <a href="https://benzinga.grsm.io/register174">Benzinga Pro data.</a>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/government/24/09/41015886/ai-chatbot-to-give-stock-picking-advice-how-does-ai-perform-in-the-markets">AI Chatbot To Give Stock-Picking Advice: How Does AI Perform In The Markets?</a></li>
</ul>
Image via Shutterstock

Fintech news covering the emerging Financial Technology services sector

Fintech

Specialty ETFs

Tech

ETFs

GOOG

GOOGL

LIVR

Did Aping Warren Buffett And Hedge Fund Managers Bring Success To This AI-Powered ETF That Launched Last Week?

Investors with a lot of money to spend have taken a bullish stance on Procter &amp; Gamble (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PG#NYSE">PG</a>).
And retail traders should know.
We noticed this today when the positions showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with PG, it often means somebody knows something is about to happen.
Today, Benzinga's options scanner spotted 8 options trades for Procter &amp; Gamble.
This isn't normal.
The overall sentiment of these big-money traders is split between 62% bullish and 37%, bearish.
Out of all of the options we uncovered, there was 1 put, for a total amount of $47,025, and 7, calls, for a total amount of $346,794.
<h3>Expected Price Movements</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $155.0 and $190.0 for Procter &amp; Gamble, spanning the last three months.
<h3>Insights into Volume &amp; Open Interest</h3>
In today's trading context, the average open interest for options of Procter &amp; Gamble stands at 2185.62, with a total volume reaching 7,765.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Procter &amp; Gamble, situated within the strike price corridor from $155.0 to $190.0, throughout the last 30 days.
<h3>Procter &amp; Gamble 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727208040_0_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>PG</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$14.1</td>
<td>$13.9</td>
<td>$14.1</td>
<td>$175.00</td>
<td>$70.5K</td>
<td>2.0K</td>
<td>52</td>
</tr>
<tr>
<td>PG</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$22.95</td>
<td>$21.6</td>
<td>$22.6</td>
<td>$155.00</td>
<td>$61.0K</td>
<td>94</td>
<td>27</td>
</tr>
<tr>
<td>PG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$9.4</td>
<td>$9.25</td>
<td>$9.4</td>
<td>$180.00</td>
<td>$58.2K</td>
<td>350</td>
<td>63</td>
</tr>
<tr>
<td>PG</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>09/27/24</td>
<td>$0.35</td>
<td>$0.3</td>
<td>$0.33</td>
<td>$175.00</td>
<td>$49.3K</td>
<td>2.9K</td>
<td>6.2K</td>
</tr>
<tr>
<td>PG</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>10/18/24</td>
<td>$2.09</td>
<td>$2.08</td>
<td>$2.09</td>
<td>$170.00</td>
<td>$47.0K</td>
<td>4.8K</td>
<td>238</td>
</tr>
</tbody>
</table>

<h3>About Procter &amp; Gamble</h3>
Since its founding in 1837, Procter &amp; Gamble has become one of the world's largest consumer product manufacturers, generating more than $80 billion in annual sales. It operates with a lineup of leading brands, including more than 20 that generate north of $1 billion each in annual global sales, such as Tide laundry detergent, Charmin toilet paper, Pantene shampoo, and Pampers diapers. Sales outside its home turf represent more than half of the firm's consolidated total.
Following our analysis of the options activities associated with Procter &amp; Gamble, we pivot to a closer look at the company's own performance.
<h3>Procter &amp; Gamble's Current Market Status</h3>
<ul>
<li>With a volume of 3,022,494, the price of PG is down -0.53% at $172.85. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 24 days.</li>
</ul>
<h3>Professional Analyst Ratings for Procter &amp; Gamble</h3>
In the last month, 3 experts released ratings on this stock with an average target price of $183.33333333333334.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from DZ Bank has elevated its stance to Buy, setting a new price target at $190. 
&#x2A; Consistent in their evaluation, an analyst from JP Morgan keeps a Overweight rating on Procter &amp; Gamble with a target price of $186. 
&#x2A; In a cautious move, an analyst from Piper Sandler downgraded its rating to Neutral, setting a price target of $174. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Procter &amp; Gamble with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

RBC Capital analyst Nik Modi maintained a Hold rating on Procter & Gamble (PG – Research Report) yesterday and set a price target of $164.00. The c...

RBC Capital Sticks to Their Hold Rating for Procter & Gamble (PG)

Fiduciary Management Q3 2024 Investment Strategy Outlook

Procter & Gamble Q1 earnings on deck: What to expect

Here's the major earnings before the open tomorrow

Today, several major companies are expected to report earnings: Autoliv (ALV), Comerica (CMA), Fifth Third Bancorp (FITB), Procter & Gamble (PG), R...

Options Volatility and Implied Earnings Moves Today, October 18, 2024

Procter & Gamble in charts: Fabric and Home Care segment sales hit an all-time high in FQ1

Procter & Gamble's first-quarter results demonstrated a mixed performance, with a 1% decrease in net sales but a 2% increase in organic sales.

Procter & Gamble Reports Mixed First Quarter Results With $21.7 Billion In Net Sales

Procter & Gamble sales drop in FQ1, forecasts cost headwinds in FY25

Stocks to watch on Friday: AXP, PG and more

Analyst Bryan Spillane of Bank of America Securities maintained a Buy rating on Procter & Gamble (PG – Research Report), with a price target of $18...

Comments

Procter & Gamble

Noticias

Últimas noticias sobre Procter & Gamble (NYSE:PG) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL